209 related articles for article (PubMed ID: 15896868)
1. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant.
Park J; Bungay PM; Lutz RJ; Augsburger JJ; Millard RW; Sinha Roy A; Banerjee RK
J Control Release; 2005 Jul; 105(3):279-95. PubMed ID: 15896868
[TBL] [Abstract][Full Text] [Related]
2. Effect of retinal permeability, diffusivity, and aqueous humor hydrodynamics on pharmacokinetics of drugs in the eye.
Krishnamoorthy MK; Park J; Augsburger JJ; Banerjee RK
J Ocul Pharmacol Ther; 2008 Jun; 24(3):255-67. PubMed ID: 18476798
[TBL] [Abstract][Full Text] [Related]
3. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
Macha S; Mitra AK
Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
[TBL] [Abstract][Full Text] [Related]
4. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
5. Drug distribution in the vitreous humor of the human eye: the effects of aphakia and changes in retinal permeability and vitreous diffusivity.
Friedrich S; Saville B; Cheng YL
J Ocul Pharmacol Ther; 1997 Oct; 13(5):445-59. PubMed ID: 9326726
[TBL] [Abstract][Full Text] [Related]
6. Computational modeling of drug distribution in the posterior segment of the eye: effects of device variables and positions.
Jooybar E; Abdekhodaie MJ; Farhadi F; Cheng YL
Math Biosci; 2014 Sep; 255():11-20. PubMed ID: 24946303
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravitreal bevacizumab (Avastin).
Bakri SJ; Snyder MR; Reid JM; Pulido JS; Singh RJ
Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
[TBL] [Abstract][Full Text] [Related]
8. Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.
Lamminsalo M; Karvinen T; Subrizi A; Urtti A; Ranta VP
Pharm Res; 2020 Oct; 37(11):226. PubMed ID: 33094404
[TBL] [Abstract][Full Text] [Related]
9. Finite element modeling of drug distribution in the vitreous humor of the rabbit eye.
Friedrich S; Cheng YL; Saville B
Ann Biomed Eng; 1997; 25(2):303-14. PubMed ID: 9084836
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of rituximab following an intravitreal injection.
Kim H; Csaky KG; Chan CC; Bungay PM; Lutz RJ; Dedrick RL; Yuan P; Rosenberg J; Grillo-Lopez AJ; Wilson WH; Robinson MR
Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
[TBL] [Abstract][Full Text] [Related]
11. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
Kane FE; Green KE
J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
[TBL] [Abstract][Full Text] [Related]
13. Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor.
Stay MS; Xu J; Randolph TW; Barocas VH
Pharm Res; 2003 Jan; 20(1):96-102. PubMed ID: 12608542
[TBL] [Abstract][Full Text] [Related]
14. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
[TBL] [Abstract][Full Text] [Related]
15. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
[TBL] [Abstract][Full Text] [Related]
17. Clearance of intravitreal daptomycin in uveitis-induced rabbit model.
Ozcimen M; Sakarya Y; Ozcimen S; Sakarya R; Goktas S; Iyisoy S; Alpfidan I; Erdogan E
Curr Eye Res; 2015 May; 40(6):598-603. PubMed ID: 25110947
[TBL] [Abstract][Full Text] [Related]
18. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment.
Loch C; Bogdahn M; Stein S; Nagel S; Guthoff R; Weitschies W; Seidlitz A
J Pharm Sci; 2014 Feb; 103(2):517-26. PubMed ID: 24311438
[TBL] [Abstract][Full Text] [Related]
19. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles.
Nieto A; Hou H; Sailor MJ; Freeman WR; Cheng L
Exp Eye Res; 2013 Nov; 116():161-8. PubMed ID: 24036388
[TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
